285 related articles for article (PubMed ID: 26033502)
21. Cancer of unknown primary site: 20 questions to be answered.
Pavlidis N; Pentheroudakis G
Ann Oncol; 2010 Oct; 21 Suppl 7():vii303-7. PubMed ID: 20943633
[TBL] [Abstract][Full Text] [Related]
22. Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
van Mourik A; Tonkin-Hill G; O'Farrell J; Waller S; Tan L; Tothill RW; Bowtell D; Fox S; Fellowes A; Fedele C; Schofield P; Sivakumaran T; Wong HL; Mileshkin L
Br J Cancer; 2023 Aug; 129(2):301-308. PubMed ID: 37225894
[TBL] [Abstract][Full Text] [Related]
23. Cancer of Unknown Primary in the Molecular Era.
Kato S; Alsafar A; Walavalkar V; Hainsworth J; Kurzrock R
Trends Cancer; 2021 May; 7(5):465-477. PubMed ID: 33516660
[TBL] [Abstract][Full Text] [Related]
24. Cancer of unknown primary site: missing primary or missing biology?
Pentheroudakis G; Briasoulis E; Pavlidis N
Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
[TBL] [Abstract][Full Text] [Related]
25. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
[TBL] [Abstract][Full Text] [Related]
27. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
28. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
29. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
Staub E; Buhr HJ; Gröne J
Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
[TBL] [Abstract][Full Text] [Related]
30. How to Diagnose and Treat a Cancer of Unknown Primary Site.
Tomuleasa C; Zaharie F; Muresan MS; Pop L; Fekete Z; Dima D; Frinc I; Trifa A; Berce C; Jurj A; Berindan-Neagoe I; Zdrenghea M
J Gastrointestin Liver Dis; 2017 Mar; 26(1):69-79. PubMed ID: 28338116
[TBL] [Abstract][Full Text] [Related]
31. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
Greco FA
Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
[TBL] [Abstract][Full Text] [Related]
32. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.
Ma W; Wu H; Chen Y; Xu H; Jiang J; Du B; Wan M; Ma X; Chen X; Lin L; Su X; Bao X; Shen Y; Xu N; Ruan J; Jiang H; Ding Y
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343328
[TBL] [Abstract][Full Text] [Related]
33. [Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].
Fujita Y; Nishio K
Gan To Kagaku Ryoho; 2009 Jun; 36(6):923-6. PubMed ID: 19542713
[TBL] [Abstract][Full Text] [Related]
34. Insights from the genetic and transcriptional characterization of a cancer of unknown primary (CUP).
Davalos V; Esteller M
EMBO Mol Med; 2020 Jul; 12(7):e12685. PubMed ID: 32558182
[TBL] [Abstract][Full Text] [Related]
35. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
Posner A; Prall OW; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW
J Pathol; 2023 Jan; 259(1):81-92. PubMed ID: 36287571
[TBL] [Abstract][Full Text] [Related]
36. [Clinical Practice of Carcinoma of Unknown Primary].
Hasegawa Y; Mukai H
Gan To Kagaku Ryoho; 2018 Jun; 45(6):891-893. PubMed ID: 30026408
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
[TBL] [Abstract][Full Text] [Related]
38. Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.
Greco FA; Oien K; Erlander M; Osborne R; Varadhachary G; Bridgewater J; Cohen D; Wasan H
Ann Oncol; 2012 Feb; 23(2):298-304. PubMed ID: 21709138
[TBL] [Abstract][Full Text] [Related]
39. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
[TBL] [Abstract][Full Text] [Related]
40. "Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?
Kolling S; Ventre F; Geuna E; Milan M; Pisacane A; Boccaccio C; Sapino A; Montemurro F
Front Oncol; 2019; 9():1546. PubMed ID: 32010631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
